Bristol-Myers lung cancer delay slams shares, keeps Merck in lead – The Fiscal Times | International News Live Blog

https://internationalnewsliveblog.wordpress.com/2017/01/23/bristol-myers-lung-cancer-delay-slams-shares-keeps-merck-in-lead-the-fiscal-times/

The Fiscal TimesBristol-Myers lung cancer delay slams shares, keeps Merck in leadThe Fiscal TimesNew YORK (Reuters) – Bristol-Myers Squibb Co shares fell 11 percent on Friday following Thursday's announcement that it would not seek accelerated approval of its immunotherapy drug combination in first-line lung cancer, further solidifying Merck … http://internationalnewslive.com/bristol-myers-lung-cancer-delay-slams-shares-keeps-merck-in-lead-the-fiscal-times/